The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
A. Kirsten, Karin Förster, E. Radeczky, Anneliese Linnhoff, Beatrix Bálint, Henrik Watz, Heather Wray(AstraZeneca (Sweden)), Lynette Salkeld(AstraZeneca (Sweden)), Marie Cullberg(AstraZeneca (Sweden)), B. Larsson(AstraZeneca (Sweden))
Cited by 90
Abstract
Related Papers
No related papers found
Powered by citation graph analysis